IVD Medical Holding (HKSE:01931) Cash And Cash Equivalents : HK$1,340 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Cash And Cash Equivalents?

IVD Medical Holding's quarterly cash and cash equivalents increased from Dec. 2022 (HK$1,139.75 Mil) to Jun. 2023 (HK$1,365.91 Mil) but then stayed the same from Jun. 2023 (HK$1,365.91 Mil) to Dec. 2023 (HK$1,339.65 Mil).

IVD Medical Holding's annual cash and cash equivalents increased from Dec. 2021 (HK$1,021.97 Mil) to Dec. 2022 (HK$1,139.75 Mil) and increased from Dec. 2022 (HK$1,139.75 Mil) to Dec. 2023 (HK$1,339.65 Mil).

IVD Medical Holding Cash And Cash Equivalents Historical Data

The historical data trend for IVD Medical Holding's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Cash And Cash Equivalents Chart

IVD Medical Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,013.57

934.85

1,021.97

1,139.75

1,339.65

IVD Medical Holding Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial									1,021.97	1,155.57	1,139.75	1,365.91	1,339.65

IVD Medical Holding Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

IVD Medical Holding (HKSE:01931) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

IVD Medical Holding Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

Executives

Leung King Sun
Wu Meizhen	2201 Interest of corporation controlled by you
China International Trust Limited	2201 Interest of corporation controlled by you
Wu Yanfeng	2201 Interest of corporation controlled by you
Wu Mingcong	2201 Interest of corporation controlled by you
Wu Junfeng	2201 Interest of corporation controlled by you
Shen Li	2201 Interest of corporation controlled by you
Nd Medical Technology Limited	2201 Interest of corporation controlled by you
Ma Zhouwei	2201 Interest of corporation controlled by you
Hong Kong Medicine Group Limited	2201 Interest of corporation controlled by you
Hknd Gene Biotechnology Limited	2201 Interest of corporation controlled by you
Fast Benefit Pharmaceutical Limited	2201 Interest of corporation controlled by you
China Smart Pharmaceutical Technology Limited	2201 Interest of corporation controlled by you
3w.com Holding Limited	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you

IVD Medical Holding (HKSE:01931) Headlines

No Headlines